# Princess Margaret Cancer Centre

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/princess-margaret-cancer-centre/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 72.4 |
| Citations | 4,677,501 |
| City | Toronto |
| Country | CA |
| Description | Princess Margaret Cancer Centre is a research organisation in Toronto, CA. OpenAlex records 35,327 works and 4,677,501 citations for it. 6,913 researchers list it as their most recent affiliation. |
| Homepage | http://www.uhn.ca/PrincessMargaret |
| OpenAlex ID | https://openalex.org/I2802654988 |
| Region | Ontario |
| Researchers | 6,913 |
| ROR ID | https://ror.org/03zayce58 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q7244693 |
| Works | 35,327 |

## University collaborators

- [Institut Gustave Roussy](https://scholariq.org/institutions/institut-gustave-roussy/)
- [The University of Texas MD Anderson Cancer Center](https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/)
- [Merck & Co., Inc., Rahway, NJ, USA (United States)](https://scholariq.org/institutions/merck-and-co-inc-rahway-nj-usa-united-states/)
- [University of California, Los Angeles](https://scholariq.org/institutions/university-of-california-los-angeles/)
- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)
- [Angeles Clinic and Research Institute](https://scholariq.org/institutions/angeles-clinic-and-research-institute/)
- [Yale University](https://scholariq.org/institutions/yale-university/)

## University papers

Showing 12 of 24.

- [Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer](https://scholariq.org/papers/docetaxel-plus-prednisone-or-mitoxantrone-plus-prednisone-for-advanced-prostate/)
- [Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma](https://scholariq.org/papers/idecabtagene-vicleucel-in-relapsed-and-refractory-multiple-myeloma/)
- [Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group](https://scholariq.org/papers/design-and-end-points-of-clinical-trials-for-patients-with-progressive-prostate/)
- [Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial](https://scholariq.org/papers/early-palliative-care-for-patients-with-advanced-cancer-a-cluster-randomised/)
- [Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms](https://scholariq.org/papers/overview-of-the-2022-who-classification-of-neuroendocrine-neoplasms/)
- [Prostate cancer](https://scholariq.org/papers/prostate-cancer/)
- [Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma](https://scholariq.org/papers/overall-survival-benefit-with-tebentafusp-in-metastatic-uveal-melanoma/)
- [Prediction of acute myeloid leukaemia risk in healthy individuals](https://scholariq.org/papers/prediction-of-acute-myeloid-leukaemia-risk-in-healthy-individuals/)
- [Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them](https://scholariq.org/papers/adverse-effects-of-androgen-deprivation-therapy-and-strategies-to-mitigate-them/)
- [Delivering affordable cancer care in high-income countries](https://scholariq.org/papers/delivering-affordable-cancer-care-in-high-income-countries/)
- [ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth](https://scholariq.org/papers/er-stress-regulated-translation-increases-tolerance-to-extreme-hypoxia-and/)
- [The Lancet Commission on prostate cancer: planning for the surge in cases](https://scholariq.org/papers/the-lancet-commission-on-prostate-cancer-planning-for-the-surge-in-cases/)

## University top topics

Showing 8 of 25.

- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.